DC Investments Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.81M Hold
68,624
1.64% 6
2026
Q1
$3.49M Hold
68,624
1.33% 13
2025
Q4
$2.02M Hold
68,624
0.9% 22
2025
Q3
$1.77M Hold
68,624
0.74% 35
2025
Q2
$1.89M Hold
68,624
0.79% 31
2025
Q1
$1.95M Buy
+68,624
New +$2.44M 1% 29

Other funds holding MRNA

DC Investments Management's MRNA Position: Q2 2026 in Review

DC Investments Management held its Moderna (MRNA) position steady in Q2 2026 at 68,624 shares worth $4.81M. The position accounts for 1.64% of the portfolio, ranked #6.

DC Investments Management first reported a position in MRNA in Q1 2025 and has held it in 6 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • DC Investments Management held 68,624 shares of Moderna worth $4.81M as of Q2 2026.
  • DC Investments Management left its Moderna share count unchanged in Q2 2026.
  • Moderna made up 1.64% of DC Investments Management's portfolio in Q2 2026, its #6 holding.
  • DC Investments Management first reported a position in Moderna in Q1 2025 and has held it in 6 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on DC Investments Management's 13F filing for Q2 2026, filed 14 Aug 2026.